Target Name: DUSP15
NCBI ID: G128853
Review Report on DUSP15 Target / Biomarker Content of Review Report on DUSP15 Target / Biomarker
DUSP15
Other Name(s): Dual specificity phosphatase 15, transcript variant 1 | VH1-related member Y | Dual specificity phosphatase 15, transcript variant 2 | Vaccinia virus VH1-related dual-specific protein phosphatase Y | VHY | Dual specificity protein phosphatase 15 | C20orf57 | DUS15_HUMAN | OTTHUMP00000214530 | dual specificity phosphatase-like 15 | DUSP15 variant 1 | FLJ40111 | DUSP15 variant 2 | Dual specificity protein phosphatase 15 (isoform b) | Dual specificity protein phosphatase 15 (isoform a) | vaccinia virus VH1-related dual-specific protein phosphatase Y | dual specificity phosphatase 15 | Dual specificity phosphatase-like 15

DUSP15: A Potential Drug Target for Neurodegenerative and Gastrointestinal Disorders

DUSP15 (Dual specificity phosphatase 15) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is involved in a variety of cellular processes, including cell signaling, metabolism, and inflammation. While the exact function of DUSP15 is not yet fully understood, it is known to play a critical role in the regulation of cellular processes that are important for human health and disease.

Recent studies have identified DUSP15 as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and gastrointestinal disorders. This has led to increased interest in the research and development of compounds that can modulate the activity of DUSP15 and improve therapeutic outcomes in these conditions.

DUSP15 and Cellular Signaling

DUSP15 is a protein that is involved in a variety of cellular signaling pathways. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular processes that are important for cell survival and growth. DUSP15 is also involved in the regulation of the TOR signaling pathway, which is involved in the regulation of cell growth and metabolism.

In addition to its role in cellular signaling, DUSP15 is also involved in the regulation of cellular metabolism. It is a regulator of the hepatic glucose output and sensitivity to insulin, which is critical for maintaining cellular energy homeostasis and preventing obesity.

DUSP15 and Cancer

DUSP15 has been identified as a potential drug target for a variety of cancer types, including breast, ovarian, and colorectal cancers. These cancers are characterized by the formation of tumors, which can grow and invade nearby tissues. The regulation of DUSP15 activity by therapeutic compounds has the potential to inhibit the growth and metastasis of these cancers.

DUSP15 has also been shown to be involved in the regulation of cell cycle progression, which is a critical step in the development of cancer. It is a regulator of the G1 phase of the cell cycle, which is important for the completion of DNA replication and the entry into the S phase.

DUSP15 and Neurodegenerative Diseases

DUSP15 is also involved in the regulation of cellular processes that are important for the prevention and treatment of neurodegenerative diseases. These conditions include Alzheimer's disease, Parkinson's disease, and Huntington's disease, which are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neurodegeneration.

DUSP15 is involved in the regulation of the production and degradation of neurotransmitters, which are critical for the function of neurons. It is also involved in the regulation of the inflammatory response, which is important for the development of neurodegenerative diseases.

DUSP15 and Gastrointestinal Disorders

In addition to its role in the regulation of cellular processes, DUSP15 is also involved in the regulation of the digestive system. It is a regulator of the Secretory port, which is the opening of the parietal layer of the intestine that allows the entry of nutrients and waste products. It is also involved in the regulation of the peristalsis, which is the muscle contractions that help to move food through the digestive tract.

DUSP15 is also involved in the regulation of the inflammatory response, which is important for the development of gastrointestinal disorders. These conditions include inflammatory bowel disease, which is characterized by the formation of inflammatory granulomas in the gut wall.

DUSP15 as a Drug Target or Biomarker

The potential drug targets for DUSP15 include inhibition of its activity in cellular signaling pathways, such as the PI3K/Akt and TOR signaling pathways, as well as modulation of its activity in the regulation of cellular

Protein Name: Dual Specificity Phosphatase 15

Functions: May dephosphorylate MAPK13, ATF2, ERBB3, PDGFRB and SNX6 (PubMed:22792334)

The "DUSP15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUSP16 | DUSP18 | DUSP19 | DUSP2 | DUSP21 | DUSP22 | DUSP23 | DUSP26 | DUSP28 | DUSP29 | DUSP3 | DUSP4 | DUSP5 | DUSP5P1 | DUSP6 | DUSP7 | DUSP8 | DUSP8P5 | DUSP9 | DUT | DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1